Drug Development for Rare Diseases
eBook - ePub

Drug Development for Rare Diseases

  1. 222 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Drug Development for Rare Diseases

About this book

A disease is defined as rare if the prevalence is fewer than 200, 000 in the United States. It is estimated that there are more than 7, 000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders. This book is proposed

to give an overview of the common issues facing rare disease drug developers, summarize challenges specific to clinical development in small populations, discuss drug development strategies in the evolving regulatory environment, explain generation and utilization of different data and evidence

inside and beyond clinical trials, and use recent examples to demonstrate these challenges and the development strategies that respond to the challenges.

Key Features:

• Rare disease.

• Drug development.

• Innovative clinical trial design.

• Regulatory approval.

• Real-world evidence.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Drug Development for Rare Diseases by Bo Yang, Yang Song, Yijie Zhou, Bo Yang,Yang Song,Yijie Zhou in PDF and/or ePUB format, as well as other popular books in Mathematics & Pharmacology. We have over one million books available in our catalogue for you to explore.

Information

Edition
1
Subtopic
Pharmacology

Table of contents

  1. Cover
  2. Half Title
  3. Series Page
  4. Title Page
  5. Copyright Page
  6. Table of Contents
  7. Editors
  8. Contributors
  9. 1. Introduction to Rare Disease Therapy Development
  10. 2. Challenges and Opportunities in Rare Disease Drug Development
  11. 3. Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations
  12. 4. Clinical Trial Design and Analysis Considerations for Rare Diseases
  13. 5. Use of Real-World Evidence to Support Drug Development
  14. 6. Clinical Development of Pediatric Program within Rare Diseases
  15. 7. Use of Modeling and Simulation in Support of Drug Development for Rare Diseases
  16. 8. Case Studies of Rare Disease Drug Development
  17. Index